Answer
The Bio Products Laboratory Limited human tetanus immunoglobulin product is intended for intramuscular administration; for prophylaxis, subcutaneous administration is permitted if intramuscular injection is contraindicated by bleeding disorders, although clinical efficacy data supporting subcutaneous administration are lacking.
Sources for this answer
- Human Tetanus ImmunoglobulinBio Products Laboratory Limited · emc · SmPC §4.2 Posology and method of administration · Version 8Document updated
Sources checked